Published in Am J Community Psychol on June 01, 1996
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr (2008) 3.14
Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Rep (1998) 2.65
The network approach and interventions to prevent HIV among injection drug users. Public Health Rep (1998) 1.96
Social networks, risk-potential networks, health, and disease. J Urban Health (2001) 1.94
HIV prevention research: accomplishments and challenges for the third decade of AIDS. Am J Public Health (2000) 1.73
Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat (2006) 1.65
Neighborhoods and HIV: a social ecological approach to prevention and care. Am Psychol (2013) 1.37
Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil (2011) 1.30
HIV prevention among injection drug users: the need for integrated models. J Urban Health (2003) 1.22
A social network profile and HIV risk among men on methadone: do social networks matter? J Urban Health (2006) 1.20
A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability. Harm Reduct J (2008) 1.19
Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection. J Urban Health (2005) 1.15
Peer norms and consistent condom use with female sex workers among male clients in Sichuan province, China. Soc Sci Med (2010) 1.13
Mobilizing homeless youth for HIV prevention: a social network analysis of the acceptability of a face-to-face and online social networking intervention. Health Educ Res (2012) 1.07
Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse (2006) 1.02
Effects of a social network HIV/STD prevention intervention for MSM in Russia and Hungary: a randomized controlled trial. AIDS (2015) 1.01
A question of trust: user-centered design requirements for an informatics intervention to promote the sexual health of African-American youth. J Am Med Inform Assoc (2013) 0.98
Drug network characteristics and HIV risk among injection drug users in Russia: the roles of trust, size, and stability. AIDS Behav (2011) 0.95
Social networks of PLHA in Uganda: implications for mobilizing PLHA as agents for prevention. AIDS Behav (2011) 0.92
The syndemic effects of intimate partner violence, HIV/AIDS, and substance abuse on depression among low-income urban women. J Urban Health (2013) 0.92
HIV Clients as Agents for Prevention: A Social Network Solution. AIDS Res Treat (2012) 0.86
Project neighborhoods in action: an HIV-related intervention project targeting drug abusers in Washington, DC. J Urban Health (1999) 0.83
HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV (2016) 0.82
Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago. Subst Use Misuse (2010) 0.81
An exploratory study of HIV-prevention advocacy by persons in HIV care in Uganda. Afr J AIDS Res (2011) 0.79
What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. Int J Equity Health (2005) 0.79
Personal social network factors associated with overdose prevention training participation. Subst Use Misuse (2012) 0.77
Social network members' roles and use of mental health services among drug users in New York City. J Behav Health Serv Res (2013) 0.76
Impact of a community popular opinion leader intervention among African American adults in a southeastern United States community. AIDS Educ Prev (2015) 0.75
A qualitative exploration of travel-related risk behaviours of injection drug users from two Slovene regions. Harm Reduct J (2011) 0.75
Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review. AIDS Behav (2016) 0.75
HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA (2000) 8.45
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med (1996) 5.77
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health (1996) 5.45
Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
Self-reported antiretroviral therapy in injection drug users. JAMA (1998) 4.75
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med (2001) 4.68
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology (1999) 4.11
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) (1995) 3.85
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA (1992) 3.81
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 3.68
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (2001) 3.56
The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev (2004) 3.41
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA (1992) 3.07
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol (1994) 2.81
Factors associated with adolescent initiation of injection drug use. Public Health Rep (2001) 2.73
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68
Correlates of HIV infection among young adult short-term injection drug users. AIDS (2000) 2.63
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol (1997) 2.55
Risk factors for HIV infection among young adult men in northern Thailand. JAMA (1993) 2.53
Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend (1995) 2.51
Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol (1997) 2.48
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
Interorganizational relationships among HIV/AIDS service organizations in Baltimore: a network analysis. J Urban Health (2001) 2.43
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol (1997) 2.32
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol (2003) 2.32
People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.26
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis (1995) 2.25
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet (1986) 2.14
The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand. AIDS (1995) 2.12
Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med (1995) 2.08
Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. Am J Epidemiol (2007) 2.07
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction (1993) 2.01
Transmission of HIV-1 within a statewide prison system. AIDS (1988) 2.00
Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res (2008) 1.95
Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect Control Hosp Epidemiol (1995) 1.95
Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev (1994) 1.87
Drinking during pregnancy. J Stud Alcohol (1976) 1.84
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control (1995) 1.83
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother (1986) 1.79
Gender differences in the initiation of injection drug use among young adults. J Urban Health (2000) 1.78
Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann Epidemiol (2001) 1.77
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1991) 1.76
Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol (1997) 1.76
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A (1998) 1.72
Human immunodeficiency virus infection and self-treatment for sexually transmitted diseases among northern Thai men. Sex Transm Dis (1996) 1.72
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health (1999) 1.71
My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol (1994) 1.71
Correlates of AIDS knowledge in samples of the general population. Soc Sci Med (1993) 1.70
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS (2000) 1.70
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health (1991) 1.68
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health (2001) 1.67
Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am J Drug Alcohol Abuse (1999) 1.66
Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health (1991) 1.66
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol (1995) 1.65
Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Rep (2002) 1.65
Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1990) 1.65
Inner-city women at risk for cervical cancer: behavioral and utilization factors related to inadequate screening. Prev Med (1990) 1.63
Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol (1991) 1.62
The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend (1996) 1.59
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med (1996) 1.59
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol (1993) 1.59
Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr (1999) 1.57
Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend (2001) 1.57
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol (2000) 1.57
An epidemiologic study of headache among adolescents and young adults. JAMA (1989) 1.57
Gastrointestinal histoplasmosis. Dig Dis Sci (1988) 1.54
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis (1996) 1.53
Measurement of HIV risk behaviors among intravenous drug users. Br J Addict (1992) 1.53
Cancer preventive screening behavior among elderly women. Prev Med (1982) 1.53